|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1016 W Jackson Blvd |
Address2 | #1073 |
| City | Chicago |
State | IL |
Zip Code | 60607 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400348610-12
|
||||||||
|
6. House ID# 403510000
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Paul Melmeyer |
Date | 5/6/2026 3:55:28 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Sent MDA Comments to House Oversight and Investigations Subcommittee on Hearing on Fraud in Medicaid
Joined Coalition Comments to Centers for Medicare and Medicaid Services (CMS) on HHS Notice of Benefit and Payment Parameters for 2027 Proposed Rule
Coalition Comments to Congressional Appropriations Leaders Re: FY2027 Support for National Institutes of Health (NIH)
Joined Coalition Comments to Congress Urging Support for the Lowering Costs for Caregivers Act (3.10.2026)
Joined Coalition Comments to U.S. Senate Leadership in Support of the Give Kids a Chance Act
Joined Coalition Comments from Partnership to Protect Coverage (PPC) to House Ways and Means Committee re: Full Committee Hearing with Health Insurance CEOs
Joined Coalition Comments from Partnership to Protect Coverage (PPC) to House Energy and Commerce Committee on Lowering Health Care Costs for All Americans: An Examination of Health Insurance Affordability Hearing
Sent MDA Comments to U.S. Department of Health and Human Services (HHS) on Proposed Rule Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance
Joined Coalition Comments from Patient Advocacy Organizations Urging the U.S. Senate to Extend ACA Tax Credits
Advocated for the introduction and passage of the ACT for ALS
Advocated for the passage of the Alleviating Barriers to Caregiving Act
Supported the Accelerating Kids' Access to Care Act
Supported Pharmacy Benefit Manager (PBM) Reform Patient Priorities
Expressed opposition to effort that caps indirect costs in NIH grants to 15%
Supported efforts to add FSHD to the Peer Reviewed Medical Research Program
Supported the reauthorization of the Rare Pediatric Disease PRV Program as part of the Gives Kids a Chance Act
Supported the reintroduction of the MVP Act
Supported the reintroduction of the Patient Access Act
Supported the introduction of legislation that would better facilitate wheelchair repair
Supported legislation that increases access to home and community-based services
Supported the HEARD Act
Advocated for the passage of the Newborn Screening Saves Lives Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AVI
16. Specific lobbying issues
Encouraged Congress to maintain its oversight of the implementation of the FAA Reauthorization Act of 2024.
Joined Coalition Comments to U.S. Department of Transportation on Proposed Guidance on Investigatory and Enforcement Policies and Procedures
Filed MDA Comments to U.S. Department of Transportation on Proposed Guidance on Investigatory and Enforcement Policies and Procedures
Joined Coalition Comments to U.S. Department of Transportation on Disability Complaint Reporting Requirements
Filed MDA Comments to U.S. Department of Transportation on Disability Complaint Reporting Requirements
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Federal Aviation Administration (FAA), Transportation - Dept of (DOT), U.S. Access Board - Architectural & Transportation Barriers Compliance Board
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Supported efforts to add FSHD to the Peer Reviewed Medical Research Program
Supported robust appropriations for the NIH, CDC, FDA, and other critical agencies for our community
Coalition Comments to Congressional Appropriations Leaders Re: FY2027 Support for National Institutes of Health (NIH)
Joined Coalition Comments to FY2027 House Labor, Health and Human Services, and Education Appropriations Subcommittee for the Assistive Technology (AT) Act
Joined Coalition Comments to FY2027 Senate Subcommittee on Transportation, Housing, Urban Development, and Related Agencies Appropriations for the U.S. Access Board
Joined Coalition Comments to Congressional Appropriations Leaders Re: FY2027 Support for ALS Programs
Joined Coalition Comments to the House Appropriations Subcommittee on Labor, HHS, and Education Request for the National Institutes of Health (NIH) for Fiscal Year (FY) 2027
Sent MDA Comments to U.S. House of Representatives Leadership in Support of H.R. 7148, Consolidated Appropriations Act of 2026
Sent Coalition Comments to Congressional Leadership re: NIH FY26 Appropriations
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Defense - Dept of (DOD), Education - Dept of, U.S. Access Board - Architectural & Transportation Barriers Compliance Board, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Expressed opposition to effort that caps indirect costs in NIH grants to 15%
Supported efforts to add FSHD to the Peer Reviewed Medical Research Program
Supported the reauthorization of the Rare Pediatric Disease PRV Program as part of the Gives Kids a Chance Act
Joined Coalition Comments to Congressional Appropriations Leaders Re: FY2027 Support for National Institutes of Health (NIH)
Joined Coalition Comments to Congressional Appropriations Leaders Re: FY2027 Support for ALS Programs
Joined Coalition Comments to the House Appropriations Subcommittee on Labor, HHS, and Education Request for the National Institutes of Health (NIH) for Fiscal Year (FY) 2027
Advocated for the introduction and passage of the ACT for ALS
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Supported the Accelerating Kids' Access to Care Act
Supported the reintroduction of the MVP Act
Supported the reintroduction of the Patient Access Act
Supported the reintroduction of the ALS Better Care Act
Supported the reintroduction of the Access to Genetic Counseling Services Act
Sent MDA Comments to House Oversight and Investigations Subcommittee on Hearing on Fraud in Medicaid
Joined Coalition Comments to Centers for Medicare and Medicaid Services (CMS) on HHS Notice of Benefit and Payment Parameters for 2027 Proposed Rule
Joined Coalition Comments to Centers for Medicare and Medicaid Services (CMS) on H.R. 1 HCBS Waiver
Supported the Alleviating Barriers to Caregiving Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Social Security Administration (SSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Supported the Accelerating Kids' Access to Care Act
Supported the reintroduction of the Patient Access Act
Joined Coalition Comments from Partnership to Protect Coverage (PPC) to House Ways and Means Committee re: Full Committee Hearing with Health Insurance CEOs
Joined Coalition Comments from Partnership to Protect Coverage (PPC) to House Energy and Commerce Committee on Lowering Health Care Costs for All Americans: An Examination of Health Insurance Affordability Hearing
Joined Coalition Comments from Patient Advocacy Organizations Urging the U.S. Senate to Extend ACA Tax Credits
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Joined Coalition Comments to FY2027 Senate Subcommittee on Transportation, Housing, Urban Development, and Related Agencies Appropriations for the U.S. Access Board
Joined Coalition Comments to House Energy and Commerce Committee on Subcommittee AV and Motor Vehicle Markup
Joined Coalition Comments to U.S. Department of Transportation on Proposed Guidance on Investigatory and Enforcement Policies and Procedures
Filed MDA Comments to U.S. Department of Transportation on Proposed Guidance on Investigatory and Enforcement Policies and Procedures
Joined Coalition Comments to U.S. Department of Transportation on Disability Complaint Reporting Requirements
Filed MDA Comments to U.S. Department of Transportation on Disability Complaint Reporting Requirements
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Federal Aviation Administration (FAA), U.S. HOUSE OF REPRESENTATIVES, Transportation - Dept of (DOT), U.S. Access Board - Architectural & Transportation Barriers Compliance Board, Energy - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Joined Coalition Comments to FY2027 House Labor, Health and Human Services, and Education Appropriations Subcommittee for the Assistive Technology (AT) Act
Joined Coalition Comments to U.S. Department of Education on Concerns on Proposal to Modify the Definition of Professional Degrees and to Implement Caps on Federal Student Loan Payments
17. House(s) of Congress and Federal agencies Check if None
Education - Dept of, U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code RET
16. Specific lobbying issues
Advocated for the Social Security Claims Processing Improvement Act
Supported the ABC Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Social Security Administration (SSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Wood |
|
|
|
Paul |
Melmeyer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Supported Pharmacy Benefit Manager (PBM) Reform Patient Priorities
Joined Coalition Comments to U.S. Senate Leadership in Support of the Give Kids a Chance Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Joel |
Cartner |
|
|
|
Paul |
Melmeyer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
Joined Coalition Comments to House Judiciary Committee Re: Opposition to H.R. 6453, ADA 30 Days to Comply Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOU
16. Specific lobbying issues
Sent MDA Comments to U.S. Department of Housing and Urban Development on Implementation of the Fair Housing Acts Disparate Impact Standard Proposed Rule
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Housing & Urban Development - Dept of (HUD)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Wood |
|
|
|
Paul |
Melmeyer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Joined Coalition Comments to House Veterans Affairs Committee, Subcommittee on Oversight and Investigations Re: Opposition to Discussion Draft of Veterans Care Protection Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Shannon |
Wood |
|
|
|
Joel |
Cartner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |